Mekonos

Coupling digital microfluidics with nanoengineered MEMS onto a single integrated chip for cell/gene therapies

Visit Mekonos Website
Mekonos

“For being a small investor in our company, TDK has done an unbelievable job in engaging with our company, helping with marketing, advice, and feedback.”

  • Anil Narasimha
  • Co-Founder and CEO, Mekonos

Portfolio News

TDK Ventures Backs MEMS-Based Genome Editing Tools Company, Mekonos

Learn about TDK Ventures’ role in empowering Mekonos to refine cell engineering with MEMS, paving the way for advanced therapies.

Media Coverage

Stories From Other Sources

TDK Backs Scalable Cell Engineering with Mekonos

Nov 12, 2021

Supporting Team

  • Engagement

Geetha Dholakia

Portfolio Program Director
  • Fund 2

Marc Bouchet

Senior Investment Associate
  • Fund EX1

Anil Achyuta

Investment Managing Director